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Abstract Coronary computed tomography (CT) allows for
the acquisition of thin slices of the heart and coronary arteries,
which can be used to detect and quantify coronary artery cal-
cium (CAC), a marker of atherosclerotic cardiovascular dis-
ease. Despite the proven clinical value in cardiac risk prog-
nostication, there remain concerns regarding radiation expo-
sure from CAC CT scans. There have been several recent
technical advancements that allow for significant radiation
dose reduction in CAC scoring. This paper reviews the clini-
cal utility and recent literature in low radiation dose CAC
scoring.
Keywords Coronary artery calcium (CAC) scoring . Low
dose radiation . Iterative Reconstruction . Rescan variability .
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Introduction
Coronary computed tomography (CT) allows for the acquisi-
tion of thin slices of the heart and coronary arteries, which can
be used to detect and quantify coronary calcium, a marker of
atherosclerotic cardiovascular disease (ASCVD). Given the
utility of coronary artery calcium (CAC) scoring in assessing
ASCVD risk, the 2010 American College of Cardiology
Foundation/American Heart Association (BACC/AHA^)
Guideline for Assessment of Cardiovascular Risk in
Asymptomatic Adults gave CAC scoring a class IIA recom-
mendation suggesting that it was reasonable to consider in
asymptomatic adults at intermediate coronary heart disease
risk (10 to 20 % 10-year Framingham risk) [1]. However,
the use of a CAC CTexposes the patient to ionizing radiation.
A study fromKimKP, et al. has found significant variability in
the radiation doses delivered at different sites performing
CAC scoring with radiation doses ranging from 1 to even as
high as 8–10 mSv [2]. Thus, the benefits of coronary artery
calcium quantification should be weighted against the risks of
exposure to ionizing radiation [1].
The Clinical Use of Coronary Artery Calcium
The aforementioned 2010 ACC/AHA risk assessment guide-
line, which included six studies of 27,622 asymptomatic pa-
tients, found that the 11,815 patients that had CAC scores=0
had a very low rate (0.4 %) of coronary heart disease deaths or
myocardial infarction events over the subsequent 3 to 5 years
[1]. A more recent paper by Valenti V, et al. has found that this
Bwarranty period^ for asymptomatic individuals without CAC
extends out to 15 years [3•]. However, for those patients with a
CAC score between 100 and 400, a CAC score of 400 to
1000, and a CAC score greater than 1000 were 4.3, 7.2, and
10.8 times more likely respectively to have an event [1]. In
addition, in a landmark study from theMulti-Ethnic Society of
Atherosclerosis, Detrano et al. analyzed data on 6722 patients
in four racial or ethnic groups and found that increased CAC
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scores between 101 and 300 and above 300 were related to
higher, almost 8-fold and almost 10-fold, respectively, in-
creased risk of adverse ASCVD events regardless of baseline
risk [4].
Thus, the general utility of CAC scoring has been in risk
prognostication; that is, if patients are found to have an ele-
vated CAC score, this portends a higher risk of ASCVD,
which can be used to implement more aggressive CAD risk
factor modification including aspirin and statin use as well as
lifestyle modifications and increased adherence to medica-
tions [1]. In fact, Taylor et al. evaluated the association be-
tween CAC score and subsequent aspirin and statin usage in
1640 patients between ages 40 to 50 years in the Prospective
Army Coronary Calcium Project cohort with a follow-up of
six years and found that patients with a CAC score of greater
than zero were three times more likely to receive a statin and
also significantly more likely to receive an aspirin or both [5].
The EISNER study, a prospective randomized trial, assigned
2137 volunteers to either undergo or not undergo CAC scan-
ning prior to risk factor counseling and found that those pa-
tients that received CAC scanning were more likely to have
improved risk factor modification including improvement in
systolic and diastolic blood pressure, total cholesterol, low-
density lipoprotein cholesterol, triglycerides, weight, and
Framingham risk score [6]. The authors also found that there
was no increase in downstream medical testing or cost in the
CAC scanning group because the increased resource utiliza-
tion and cost in the subjects with CAC≥400 was balanced by
the decreased resource utilization and cost in the subjects with
CAC=0.
Subsequent to the 2010 ACC/AHA Guidelines on cardio-
vascular risk in asymptomatic patients, the 2013 ACC/AHA
guidelines in cholesterol management recommendation to as-
sess a patient’s ASCVD 10-year risk using the pooled cohort
equations has increased the number of patients eligible for
statin therapy [7]. After the release of these guidelines, Nasir
et al. recently evaluated the implications of CAC scoring in
reclassifying patients from a risk category in which statins are
recommended to one in which they are not in the Multi-Ethnic
Study of Atherosclerosis (MESA), which included 4758 pa-
tients between the ages of 45 and 75 with a median follow-up
of about 10 years [8•]. Using the pooled cohort equations,
50 % of patients in the study were recommended for
moderate- to high-intensity statins (for LDL≥190, for LDL
70 to 189 in diabetics, or most commonly for 10-year
risk ≥ 7.5 %), and 12 % were considered for moderate-
intensity statins (ASCVD 10-year risk 5–7.5 %). Of those
patients recommended for statins, 41 % had a CAC=0 with
a 5.2 ASCVD event rate/1000 person-years, and of those pa-
tients considered for moderate-intensity statins, 57 % had a
CAC=0 with a lower ASCVD event rate of 1.5/1000 person-
years. Of those 38 % of patients who were not candidates for
statin using the pooled cohort equations (ASCVD 10-year risk
<5 %), a larger 79 % of patients had a CAC=0 with an even
lower ASCVD event rate of 1.2/1000 person-years. Overall,
the absence of CAC reclassifies about 50 % of candidates as
not eligible for statin therapy and results in a very low risk of
future ASCVD events in asymptomatic adults.
While CAC scoring may further refine the risk categoriza-
tion of patients, radiation exposure was one of the cited rea-
sons that the updated 2013 ACC/AHA Guideline on the
Assessment of Cardiovascular Risk downgraded CAC scoring
from a class IIA recommendation in the 2010 ACC/AHA
guidelines to a class IIB recommendation in asymptomatic,
intermediate risk patients for whom the decision to treat based
on risk is uncertain after formal risk estimation [9]. However,
recent advances in radiation dose reduction for CAC scoring
may enable a re-examination of these concerns.
Strategies for Low Radiation Dose Coronary Artery
Calcium Scoring
There are multiple methods to modulate radiation dose to
follow the principles of Bas low as reasonably achievable^
or "ALARA^ in CAC scoring. However, it is important to
maintain the image quality within an acceptable degree of
image noise. The Society of Cardiovascular Computed
Tomography has published guidelines for several of these
methods [10]. A brief summary of these guidelines follows.
First, acquiring the CT images via ECG-triggered axial or
sequential imaging is important. It is advantageous to avoid
retrospective ECG-gating. Secondly, current guidelines rec-
ommend CAC imaging at a peak tube voltage of 120 kVp.
This threshold was chosen to maintain similar quantification
to prior electron beam computed tomography (EBCT) [11].
This allows the use of 130 Hounsfield units (HU) as the stan-
dard threshold for quantifying CAC according the Agatston
method. Low tube current values (in mA) are recommended
and may be adjusted based on the patient’s body habitus. The
scan length should be minimized to be limited to the coronary
vasculature and the heart. This may be planned from the scout
images. Slice thickness has been standardized to 2.5–3 mm
based on the prior experience with EBCT [12]. With these
standards in mind, there have been several recent advances
in dose reduction strategies.
Low kV/mA Calcium Scoring
Decreasing the tube current/voltage is a previously attempted
method of reducing the radiation dose that has been evaluated
in several studies; however, this methodology is found to
cause a significant increase in image noise. Dey et al. evalu-
ated 66 consecutive patients using an anthropomorphic heart/
thorax phantom on a dual source CT (DSCT) (Siemens
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Medical Systems, Erlangen, Germany) at both standard 150
mAs and 85 or 120 mAs based on the patient’s body mass
index and found no significant difference between Agatston
and calcium volume scores when comparing individual data
points [13]. There was 98 % agreement in Agatston score
severity between the standard and low-dose scans. However,
image noise was significantly higher for the low-dose scans
(18.8±5.5 HU) than that for standard scans (15.2±4.8 HU),
though both were within the target limits in guidelines.
To represent the same physical density at of CAC at a 130-
HU threshold, Nakazato, et al. tested the effect of differing HU
thresholds with tube current output using an anthropomorphic
phantom and established that a 147-HU threshold at 100 kV
would best correlate with a 130-HU threshold at 120 kV [14].
Subsequently, Marwan et al. evaluated 150 consecutive pa-
tients using high-pitch spiral acquisition on a DSCT
(Siemens Medical Systems, Erlangen, Germany) at 120 kV
(with a 130-HU threshold) and 100 kV (with the previously
established 147-HU threshold and at a 130-HU threshold) and
also found that mean image noise was significantly increased
in the 100-kV radiation scans (130-HU threshold) compared
to the standard radiation scans at 27±7 and 20±5 HU, respec-
tively [15]. While there was overestimation at 100 kV (130-
HU threshold), this improved with the 100 kV (147-HU
threshold). With regard to zero scores, when compared to
120-kV imaging, three patients at 100 kV (147 HU) were
reported to have calcium. Newton et al. utilized a 320-
detector row CT (Toshiba Medical Systems, Tokyo, Japan)
at tube currents from 40 to 300 mA adjusted to several body
size parameters in 43 patients and demonstrated that using a
scout attenuation coefficient allowed for the lowest potential
reduction in mean radiation dose from 1.86 to 0.88 mSv while
maintaining statistically significant correlation coefficients of
0.66 to 0.86 [16].
Use of Iterative Reconstruction
Iterative Reconstruction (IR) is a newer reconstruction algo-
rithm that is being evaluated for use in CAC scoring as it
allows for reduction in image noise, improved image quality,
and lower radiation requirements (Fig. 1). IR methods have
three steps: a forward projection of the volumetric object es-
timate creates artificial raw data (may be an image from the
initial FBP), the real measured data is compared to the artifi-
cial raw data and creates a correction term, and the correction
term is projected back onto the volumetric object estimate
[17]. There are several IR techniques, which include algebraic
reconstruction methods that model the geometry of the acqui-
sition process, statistical methods that incorporate counting
statistics of the detected photons, and model-based methods
that model the acquisition process as accurately as possible.
Research-based IR usually utilizes a combination of statistical
and model-based IR techniques.
Iterative reconstruction has been evaluated in several do-
mains, most notably in coronary CTA [18–20], as well as for
other organ scanning such as lung and in re-operative cardiac
surgery [21–23]. There have been several recent publications
evaluating iterative reconstruction for CAC both in anthropo-
morphic phantoms and in patients at standard radiation doses
with varying success (Table 1).
Schindler et al. evaluated the influence of image-based and
raw data-based IR algorithms on the Agatston score and sub-
sequent cardiac risk stratification in 110 patients undergoing
routine CAC scoring [24•]. A 64-DSCT scanner (Siemens
Medical Systems, Erlangen, Germany) was used to obtain
the phantom and patient images, which were reconstructed
using traditional FBP, image-based iterative reconstruction
(IRIS), and raw data-based sinogram-affirmed iterative recon-
struction (SAFIRE). In vitro, mean Agatston scores for FBP,
IRIS, and SAFIREwere comparable, and in the patient cohort,
the Agatston scores were not significantly different for FBP,
IRIS, and SAFIRE in paired comparisons. There was excel-
lent agreement of categorization in Agatston risk percentiles
with both IRIS and SAFIRE compared to FBP with identical
percentile categories in 98.2 % with IRIS and 97.3 % with
SAFIRE. The authors did notice that there was a non-
significant trend toward lower scores for high-density lesions
in the in vitro study using IR.
Kurata et al. also evaluated the effect of SAFIRE at
10, 20, 30, 40, and 50 % algorithms compared to FBP
on CAC scoring in 70 patients using a 64-DSCT
(Siemens Healthcare) [25]. An increased proportion of
SAFIRE was significantly associated with a decrease in
the CAC Agatston, volume, and mass scores, though
attenuation within the aorta was unaffected. The 50 %
SAFIRE can result in a negative CAC score while 10 %
SAFIRE can increase the CAC score in a proportion of
patients. There were three patients that had an Agatston
score greater than zero using FBP that decreased to zero
using more than 20 % SAFIRE.
Gebhard et al. studied the effect of applied adaptive statis-
tical iterative reconstruction (ASIR) compared with FBP on
CAC scoring in 50 patients within 90 days using a 64-slice CT
scanner (GE Healthcare, Milwaukee, WI) [26]. The authors
found that the use of ASIR algorithms at 20, 40, 60, 80, and
100 %was associated with a linear reduction in noise (median
reduction of 50 %) and improvement in signal to noise ratio,
but a significant decrease in CAC score. With increased per-
centage of ASIR, volume and Agatston scores (22 %) de-
creased. The authors postulated that the mass score might
have lower susceptibility to partial volume effects. At 80 and
100%ASIR, 18% of patients were re-assigned to a lower-risk
group while at 20 and 40%ASIR, there was the least variation
in Agatston score and significant noise reduction.
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Van Osch et al. also evaluated the impact of ASIR on CAC
scoring compared to FBP in 112 patients using a hybrid 64-
slice single-photon emission CT/CT (SPECT/CT) (GE
Healthcare, Milwaukee, WI) [27]. The authors only utilized
a 100 % ASIR algorithm compared to FBP and found that
Agatston, mass, and volume scores using ASIR were lower
for all patients compared to FBP with a very strong correlation
between Agatston scores using ASIR and FBP. Importantly, a
large number of patients, 29 %, were moved to a lower-risk
category using ASIR instead of FBP using five risk categories
and 13 % of patients that had their Agatston score reduced to
zero from greater than zero with FBP.
Takahashi et al. compared CAC scores in 352 consecutive
patients using FBP (ASIR 0 %), ASIR-FBP composites
(ASIR 30, 50, 70 %), and ASIR 100 % using a 64-slice mul-
tidetector CT (MDCT; GE Healthcare, Milwaukee, WI) and
found that Agatston and calcium volume scores decreased as
the percentage of ASIR increased and differed significantly
among the five techniques [28]. Severity classification did not
differ significantly between FBP and ASIR 30 % (Agatston
Fig. 1 Example of CTs with
filtered back projection (FBP)
versus iterative reconstruction
(IR) at standard radiation dose
(BStd.^) and low radiation dose
(BLow^). There is a circle
signifying the region of interest
(ROI) in the ascending aorta
measuring the image noise as the
standard deviation of the ROI in
Hounsfield units (HU). Image
noise is the highest for low dose
FBP, while image noise between
Std. Dose FBP and Low Dose IR
is similar as evidenced by the HU
measured by the ROI and the
degree of pink speckling
identified by the CAC scoring
software. a Low Dose IR; b Std.
Dose FBP; c Std. Dose IR; d Low
Dose FBP
Table 1 Summary of selected studies evaluating the use of Iterative Reconstruction for Coronary Artery Calcium Scoring
Author Year n IR algorithm Vendor Standard vs Low Radiation Median Agatston Scores
Gebhard, et al.[26] 2012 50 ASIR GE Healthcare 837.3 (FBP) vs 709.2 (ASIR 100 %)
Kurata, et al.[25] 2013 70 SAFIRE Siemens Healthcare 163.3 (FBP) vs 84.1 (SAFIRE 50 %)
Schindler, et al.[24•] 2014 110 IRIS/SAFIRE Siemens Healthcare 76.0 (FBP) vs 75.7 (SAFIRE)
Van Osch, et al.[27] 2014 112 ASIR GE Healthcare 81 (FBP) vs 53 (ASIR 100 %)
Obmann, et al.[29] 2015 68 HIR Philips Healthcare 621.4 (FBP) vs 531.8 (L7) (CAC>400)
Takahashi, et al.[28] 2015 352 ASIR GE Healthcare 119 (FBP) vs 79 (ASIR 100 %)
Szilveszter, et al.[30] 2015 567 HIR/IMR Philips Healthcare 147.7 (FBP) vs 107.0 (HIR) vs 115.1 (IMR)
n number of patients, IR iterative reconstruction, IRIS iterative reconstruction in image space, SAFIRE sinogram-affirmed iterative reconstruction,
AIDR3D adaptive iterative dose reduction 3D, ASIR adaptive statistical iterative reconstruction,HIR hybrid iterative reconstruction, IMR iterative model
reconstruction, FBP filtered back projection
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score reduced by about 10 %), but did differ significantly
between FBP and ASIR 50 %, FBP and ASIR 70 %, and
FBP and ASIR 100%with Agatston score reductions of about
17, 23, and 31 %, respectively. Noise decreased as the per-
centage of ASIR increased and among the three noise groups,
the Agatston score was not significantly influenced by ASIR
percentage.
Newer generation IR algorithms have been tested recently
as well. Obmann et al. compared hybrid iterative reconstruc-
tion (HIR) to FBP in 68 patients using a 256-slice MDCT
(Philips Healthcare, Cleveland, OH) and also found an excel-
lent correlation between Agatston scores measured in all sev-
en iteration levels with HIR and FBP [29]. In about 93 % of
HIR reconstructions at all iteration levels, the patient assign-
ment to a risk group was identical to that of the FBP recon-
structions. Szilveszter et al. also compared the effect of HIR to
FBP on CAC scoring in addition to iterative model-based
reconstruction (IMR) using a 256-slice CT (Philips
Healthcare, Cleveland, OH) in two different cohorts of pa-
tients: 63 symptomatic patients referred due to suspected
CAD and 504 asymptomatic individuals in a test population
from a National Health Examination survey [30]. The relative
differences in median CAC scores were 7.2 % for HIR and
7.3 % for IMR in the patient population. There was statistical
significance in CAC scores with HIR and IMR compared to
FBP, but not between HIR and IMR. Using HIR and IMR,
noise was reduced by 33.9 and 65.8%, respectively, compared
to FBP. In the test population, extrapolation of relative differ-
ences by IR algorithms yielded a 2.4 % change in risk strati-
fication, but did not differ significantly among the three recon-
structions and those 12 patients moved to lower-risk groups.
Use of Low Dose Radiation with Iterative
Reconstruction
After validation of IR algorithms with demonstrated improve-
ments in image noise without change in risk stratification,
several groups have tested the use of iterative reconstruction
at low radiation dose. A brief summary of these studies fol-
lows (Table 2).
Hecht et al. evaluated CAC scoring in 102 patients using a
hybrid IR algorithm on a 256-slice CT scanner (Philips
Healthcare, Cleveland, OH) at both standard radiation dosing
and 50 % of the standard radiation dosing (with increased IR
from seven to three) using a weight-based radiation dose al-
gorithm [31•]. All patients were scanned using 120 kVp. The
authors found that the correlation of the Agatston scores be-
tween the low and high dose was excellent (r=0.998) with
similar agreement for volume and mass scores. There were
significant differences in the Agatston scores of 248.4
±497.1 vs. 237.9±489.5 for standard vs. low radiation dose;
however, this had little clinical significance. All of the patients
in the lowest-risk category (zero CAC) and high-risk category
(>400 CAC) remained in the same group at both doses, and
87 % of patients were in exact agreement in the low-to-
intermediate CAC risk groups.
Choi AD et al. has demonstrated a significant reduction in
radiation dose while maintaining excellent correlation in
Agatston risk categories through the application of a novel
adaptive iterative dose reduction 3D (AIDR3D) algorithm to
CAC CTs [32•]. The authors evaluated 200 consecutive pa-
tients using 320-detector row CT (Toshiba Medical Systems,
Otawara, Japan) and were able to achieve a 70 % reduction in
radiation dose (1.38 mSv in standard dose vs. 0.37mSv in low
dose) while obtaining a 92 % agreement in Agatston risk
category between standard and low dose radiation scans.
The radiation dose was individually determined in an auto-
mated fashion by the CT scanner based on soft tissue attenu-
ation of the scout images.
In looking at lowered radiation dose protocols in a cross-
vendor fashion, Willemink et al. examined 15 ex vivo hearts
with four different radiation protocols (4.1, 3.0, 1.9, and
0.8 mGy) using four different CT scanner vendors and found
that lowering the radiation dose did not significantly change
the Agatston, mass, or volume CAC scores [33•]. Another
study by Willemink et al. evaluated the maximum achievable
dose reduction with IR using an anthropomorphic calcium
scoring phantom and a subsequent within-patient study on a
256-slice CT (Philips Healthcare, Cleveland, OH) in 30 pa-
tients that each received the four CT scans in a single session
at 100, 60, 40, and 20 % of the reference radiation dose with
FBP and HIR levels 1, 4, and 7 [34]. In the patient population,
Table 2 Summary of selected studies evaluating low-dose radiation with Iterative Reconstruction for Coronary Artery Calcium Scoring
Author Year n IR algorithm Vendor Standard vs low radiation effective dose
Hecht, et al.[31•] 2014 102 HIR Philips Healthcare 0.76 vs 0.37 mSv (mean)
Matsuura, et al.[35] 2015 77 HIR Philips Healthcare 1.20 vs 0.24 mSv (mean)
Willemink, et al.(34•) 2015 30 HIR Philips Healthcare 0.7 vs 0.2 mSv (<80 kg pts only) (median)
Choi, et al.[32•] 2015 200 AIDR3D Toshiba Medical Systems 1.38 vs 0.37 mSv (median)
n number of patients, IR iterative reconstruction, HIR hybrid iterative reconstruction, AIDR adaptive iterative dose reduction
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median Agatston scores increased with FBP while they de-
creased with IR at 20 % of the reference dose. Volume and
mass scores decreased with increasing levels of IR. The au-
thors were able to achieve an 80 % reduction in radiation dose
with reclassification rate within 15 % if the highest level of IR
is applied. In the phantom study, Agatston scores remained
unchanged between 55 and 20 mAs (40 % of the approximate
reference dose).
Matsuura et al. examined the lowest tube current and
highest iDose level for CAC scoring in 77 consecutive pa-
tients using a 256-slice MDCT (Philips Healthcare,
Cleveland, OH) [35]. Each patient had two non-contrast CT
scans at normal tube current 364mA (80 and 16mAs) for FBP
and low current 73 mA (16 mAs) with iDose level 7. The
percentage difference between FBP and HIR for the
Agatston, volume, and mass scores were 20.7, 20.7, and
27.1 %, respectively. Between FBP at standard tube current
and HIR at low tube current, there was no systematic bias in
the three different scores using the Bland-Altman analysis.
Rescan Variability
Coupled with the need for radiation dose reduction, it is im-
portant to recognize that interscan variability exists in CAC.
Even while utilizing low radiation dose strategies, the ability
to achieve low interscan variability is critically important for
CAC scoring given its prognostic significance for coronary
artery disease risk stratification and subsequent medical man-
agement. Interscan variability can be affected by the type of
scanner, the type of reconstruction algorithm, the heart rate,
and the density of the calcification. Several studies have com-
pared various CT scanners and reconstruction algorithms to
evaluate the reproducibility of CAC scoring.
Ghadri et al. examined the interscan variability of CAC
scoring on a 64-slice single source multi-detector CT (GE
Healthcare, Milwaukee, WI) and a 64-slice dual source CT
(DSCT; Siemens Medical Systems, Erlangen, Germany) in
thirty patients that were scanned on both CT scanners within
23±27 days (range 0–90 days) [36]. There was an excellent
interscan agreement of Agatston scores (r=0.976) with a co-
efficient of variation of 15.1 %. The interscan agreement was
best for Agatston scores of <1000 and decreased in patients
that had extensive calcifications. Mass scores and volume
scores also demonstrated excellent correlation (r=0.975 and
r=0.971, respectively), though volume scores had higher co-
efficient of variability of 44.9 %. The authors felt that the
variability in volume scores was more likely related to the
different software systems rather than the different scanner
types.
Detrano et al. evaluated the effect of two different types of
CT scanners and the type of calcium measurement on the
interscan variability of CAC scoring from the previously cited
Multi-Ethnic Study of Atherosclerosis (MESA) cohort of
6741 patients [37]. Each patient had two scans for CAC scor-
ing on either an electron-beam CT or a MDCT. The authors
also found excellent agreement between EBCT and MDCT
scans of about 96 % (k=0.92), but with overall mean relative
rescan differences of 20.1% for Agatston score and 18.3% for
calcium volume and interpolated volume scores. EBCTs were
more likely to demonstrate noise artifacts, and MDCTs were
more likely to demonstrate motion and misregistration
artifacts.
The aforementioned study by Willemink et al. examined
the interscan variability of four different CT vendors and IR
algorithms (Philips Healthcare with iDose levels 1 and 6,
Toshiba Medical Systems with AIDR mild and strong, GE
Healthcare with ASIR 20 and 60 %, and Siemens Healthcare
with SAFIRE 1 and 5) on CAC scoring in five ex vivo cadav-
eric hearts [33•]. The authors found significant differences in
Agatston scores between the four vendors with median
Agatston scores ranging from 332 to 469. Notably, scans done
using the CTscanner/software fromGEHealthcare resulted in
the highest Agatston scores and the lowest calcification and
mass scores.
Lastly, in the study by Choi AD, et al., the authors also
evaluated the interscan reproducibility of standard and low
radiation dose scans in 200 patients that were scanned twice
at a standard radiation dose and twice at a low radiation dose
on a 320-detector row MDCT (Toshiba Medical Systems,
Otawara, Japan) [32•]. There was an excellent rescan agree-
ment of Agatston CAC scoring classification with low IR
(91 %, k=0.87), standard FBP (93 %, k=0.91), standard IR
(92 %, k=0.89), and low FBP (90 %, k=0.88).
Conclusions
It is important to recognize that the design of appropriate
studies that advance the field of low radiation dose calcium
scoring may raise important ethical implications of radiation
exposure to patients. In the most recent studies cited this pa-
per, the combined radiation doses of multiple scans generally
fell within an accepted community standard for radiation ex-
posure. However, it is reasonable to ask at what threshold the
added radiation dose of the repeated scans would be justified
when weighed against the risks of the exposure. These risks
are balanced by the potential large-scale benefit that would be
provided to patients through practice implantation of these
techniques. The underlying principles fall within the princi-
ples outlined by the Declaration of Helsinki [38]. It is reason-
able to expect that these studies are vetted carefully by insti-
tutional review boards and that only in the absence of alterna-
tive study designs should this type of research be pursued
[39].
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In conclusion, we now have an increasing body of evidence
on multiple platforms that CAC scoring at sub-mSv radiation
doses can be performed reliably, particularly through the use of
iterative reconstruction. Future studies include newer generation
IR algorithms, combining IR algorithms with low-kV scanning
as well as newer technologies such as dual energy scanning that
may permit even lower-energy scanning. Thus, the present liter-
ature supports coronary calcium scoring at radiation doses that
allow for cardiac risk categorization lower than for screening in
other disease states such as mammography (0.7 mSv) [40], lung
cancer (1–2 mSv) [41], or colon cancer (4–5 msV) [42].
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